Emerging links between type 2 diabetes and Alzheimer's disease

被引:89
|
作者
Sridhar, Gumpeny R. [1 ]
Lakshmi, Gumpeny [1 ]
Nagamani, Gumpeny [1 ]
机构
[1] Andhra Med Coll, Endocrine & Diabet Ctr, Dept Obstet & Gynecol, Visakhapatnam 530002, Andhra Pradesh, India
来源
WORLD JOURNAL OF DIABETES | 2015年 / 6卷 / 05期
关键词
Cognition; Insulin resistance; Insulin; Butyrylcholinesterase; Dementia;
D O I
10.4239/wjd.v6.i5.744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus and Alzheimer's disease are both associated with increasing age, and each increases the risk of development of the other. Epidemiological, clinical, biochemical and imaging studies have shown that elevated glucose levels and diabetes are associated with cognitive dysfunction, the most prevalent cause of which is Alzheimer's disease. Cross sectional studies have clearly shown such an association, whereas longitudinal studies are equivocal, reflecting the many complex ways in which the two interact. Despite the dichotomy, common risk and etiological factors (obesity, dyslipidemia, insulin resistance, and sedentary habits) are recognized; correction of these by lifestyle changes and pharmacological agents can be expected to prevent or retard the progression of both diseases. Common pathogenic factors in both conditions span a broad sweep including chronic hyperglycemia per se, hyperinsulinemia, insulin resistance, acute hypoglycemic episodes, especially in the elderly, microvascular disease, fibrillar deposits (in brain in Alzheimer's disease and in pancreas in type 2 diabetes), altered insulin processing, inflammation, obesity, dyslipidemia, altered levels of insulin like growth factor and occurrence of variant forms of the protein butyrylcholinesterase. Of interest not only do lifestyle measures have a protective effect against the development of cognitive impairment due to Alzheimer's disease, but so do some of the pharmacological agents used in the treatment of diabetes such as insulin (especially when delivered intranasally), metformin, peroxisome proliferator-activated receptors. agonists, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes must be recognized as a risk for development of Alzheimer's disease; clinicians must ensure preventive care be given to control and postpone both conditions, and to identify cognitive impairment early to manage it appropriately. (C) The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:744 / 751
页数:8
相关论文
共 50 条
  • [41] Neuropathologic links between Alzheimer's disease and vascular disease
    Sparks, DL
    ALZHEIMER'S DISEASE AND RELATED DISORDERS: ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 1999, : 153 - 163
  • [42] Links between copper and cholesterol in Alzheimer's disease
    Hung, Ya Hui
    Bush, Ashley I.
    La Fontaine, Sharon
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [43] Exploring the links between obesity and Alzheimer's disease
    Petanceska, Suzana S.
    CURRENT ALZHEIMER RESEARCH, 2007, 4 (02) : 95 - 96
  • [44] What are the links between hypoxia and Alzheimer's disease?
    Lall, Rahul
    Mohammed, Raihan
    Ojha, Utkarsh
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1343 - 1354
  • [45] The Links between Cardiovascular Diseases and Alzheimer's Disease
    Leszek, Jerzy
    Mikhaylenko, Elizaveta, V
    Belousov, Dmitrii M.
    Koutsouraki, Efrosini
    Szczechowiak, Katarzyna
    Kobusiak-Prokopowicz, Malgorzata
    Mysiak, Andrzej
    Diniz, Breno Satler
    Somasundaram, Siva G.
    Kirkland, Cecil E.
    Aliev, Gjumrakch
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (02) : 152 - 169
  • [46] Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease
    Wenlu Li
    Steffen Tiedt
    Eng H. Lo
    Signal Transduction and Targeted Therapy, 8
  • [47] Proteomics Approaches to Understand Linkage Between Alzheimer's Disease and Type 2 Diabetes Mellitus
    Mirza, Zeenat
    Ali, Ashraf
    Ashraf, Ghulam Md
    Kamal, Mohammad A.
    Abuzenadah, Adel M.
    Choudhary, Adeel G.
    Damanhouri, Ghazi A.
    Sheikh, Ishfaq A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) : 213 - 225
  • [48] A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer's Disease
    Peng, Xuemin
    Fan, Rongping
    Xie, Lei
    Shi, Xiaoli
    Dong, Kun
    Zhang, Shujun
    Tao, Jing
    Xu, Weijie
    Ma, Delin
    Chen, Juan
    Yang, Yan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [49] Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment
    Li, Xiaohua
    Song, Dalin
    Leng, Sean X.
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 549 - 560
  • [50] Homocysteine: A Potential Molecular Link between Alzheimer's Disease and Type 2 Diabetes Mellitus
    Vollmer, Cyndel
    Mcnay, Ewan
    DIABETES, 2012, 61 : A428 - A428